Medpace: A Winner of AI in Biotechnology as More Clinical Trials Launch!
Reading Time: 2 minutes
Medpace is a globally operating contract research organization whose mission is to accelerate the development of safe and effective medical therapeutics. The company acts as a full-service partner for conducting clinical trials of all phases, particularly for small and medium biotech firms. The service portfolio includes study planning, clinical monitoring, biometric evaluation, and integrated laboratory services (central, bioanalytical, and core labs). Q2 Performed Outstandingly Medpace reported a very strong second quarter of 2026. Demand is...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
